Determining How Circadian Rhythm Regulates Sleep Fragmentations in Tauopathy

Principal Investigator
Masashi Tabuchi, PhD
Case Western Reserve University School of Medicine
Cleveland, OH, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$300,000
Active Dates
July 01, 2021 - June 30, 2025
Grant ID
A2021043S
Goals
The goal of this project is to elucidate how sodium channel dynamical states modulate tau pathology in circadian neurons to alter circadian rhythms and sleep.
Summary
In Aim 1, we will evaluate how inactivation states of voltage-gated sodium channels alter tau proteostasis, core clock system regulation, and circadian activity. In Aim 2, we will investigate the effect of pharmacological manipulations of inactivation states of voltage-gated sodium channels on clock neuron electrophysiology, sleep behavior, cognition, and lifespan in the adult Drosophila brain. In Aim 3, we will demonstrate that the inactivation states of voltage-gated sodium channels are altered in the iPS cells derived from human patients.
Unique and Innovative
By using Drosophila, the research proposal can precisely but rapidly capture behaviorally important molecular phenotypes of Alzheimer’s disease, and we can validate the conservation of these phenotypes in human iPS cell-derived neurons, by using our state-of-the-art data acquisition methodology of simultaneous electrophysiology and arousal/sleep measurements with sophisticated machine learning platforms to construct mathematical models to extract the features of the temporal structure of neural activity patterns. We believe that this approach is novel, and will attract worldwide attention.
Foreseeable Benefits
Completion of our study will help us address the gap in our knowledge of how alterations in voltage-gated channel states contribute to Alzheimer’s disease and related tauopathies, in the context of circadian regulation of sleep. Further, it will help pave the way towards the development of new therapeutic strategies for Alzheimer’s disease.
Related Grants
Alzheimer's Disease Research
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Alzheimer's Disease Research
Targeting Brain Cell Miscommunication to Restore Memory in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Amira Latif-Hernandez, PhD
Current Organization
Stanford University
Targeting Brain Cell Miscommunication to Restore Memory in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Amira Latif-Hernandez, PhD
Current Organization
Stanford University
Alzheimer's Disease Research
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University